Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

LM-10 is an inhibitor of tryptophan 2,3-dioxygenase (TDO; IC50 = 2 µM).1 It is selective for TDO over indoleamine 2,3-dioxygenase (IDO), monoamine oxidase A (MAO-A), and MAO-B, as well as a panel of various receptors and transporters, at 10 µM. LM-10 (1 mg/ml in the drinking water) reverses tumoral immune resistance in a TDO-overexpressing P815B mastocytoma syngeneic model using mice immunized with the P815 antigen P1A.2 Oral administration of LM-10 (50 mg/kg) prevents decreases in the number of dopaminergic neurons and increases in microglial cell volume, a marker of neuroinflammation, in the substantia nigra and inhibits decreases in intestinal transit in a mouse model of Parkinson’s disease induced by rotenone (Item No. 13995).3
WARNING This product is not for human or veterinary use.
1. Tryptophan 2,3-
2. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-
3. Pharmacological validation of TDO as a target for Parkinson’s disease. FEBS J. 288(14), 4311-4331 (2021).